CXCR2 and hepatocellular carcinoma: To demonstrate this possibility, Liu and associates modified chimeric antigen receptor-T cells (CAR-T) coated with CXCR2, which more specifically and efficiently targets hepatocellular carcinoma cells with highly expressed CXCR2 ligands (110).